ARB-HM32B-100μg / 询价
ARB-HM32B-500μg / 询价
ARB-HM32B-500μgx2 / 询价
Human/Cynomolgus Activin RIIB/ACVR2B Protein
Recombinant Human/Cynomolgus Activin RIIB/ACVR2B Protein is expressed from HEK293 with mFc (IgG1) tag at the C-terminus. It contains Ser19-Thr137 (Human) / Ser40-Thr158 (Cynomolgus) [Accession | Q13705-1(Human) / XP_045242398.1(Cynomolgus)].
The protein has a predicted MW of 39.32 kDa. Due to glycosylation, the protein migrates to 50-70 kDa based on Bis-Tris PAGE result.
> 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLC
Less than 1 EU per μg by the LAL method.
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
-20 to -80°C for 12 months as supplied from date of receipt.
-80°C for 3 months after reconstitution.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Human/Cynomolgus Activin RIIB on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human/Cynomolgus Activin RIIB is greater than 95% as determined by SEC-HPLC.
Immobilized Human Activin A, No Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human/Cynomolgus Activin RIIB, mFc Tag with the EC50 of 41.4 ng/ml determined by ELISA (QC Test).
Immobilized Human/Cynomolgus Activin RIIB, mFc Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-Activin RIIB Antibody, hFc Tag with the EC50 of 6.9 ng/ml determined by ELISA.
Immobilized Human/Mouse/Rat GDF-8, No Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Human/Cynomolgus Activin RIIB, mFc Tag with the EC50 of 20.8ng/ml determined by ELISA.
ActRIIB (activin receptor type-2B) is an activin receptor subtype constitutively expressed in the whole body, playing a role in cellular proliferation, differentiation, and metabolism. For its various physiological activities, ActRIIB interacts with activin and multiple other ligands including myostatin (MSTN), growth differentiation factor 11 (GDF11), and bone morphogenetic protein 9 (BMP9).
Activin receptor type-2B; ACVR2B; Activin RIIB
Sakamoto K, Kanematsu-Yamaki Y, Kamada Y, Oka M, Ohnishi T, Miwa M, Asami T, Inooka H. Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology. Biochem Biophys Rep. 2017 Jun 10;11:33-39. doi: 10.1016/j.bbrep.2017.06.001. PMID: 28955765; PMCID: PMC5614685.
